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Introduction {#sec1}
============

Unicellular parasites of the genus *Plasmodium* are the causative agent of malaria, with annual fatalities close to 1.25 million ([@bib19]). Development of mammalian *Plasmodium* species proceeds via asexual exoerythrocytic proliferation and intraerythrocytic multiplication occurring in mammalian liver hepatocytes and erythrocytes, respectively, whereas sexual development and sporogony occur in the mosquito. *Plasmodium* belongs to the phylum *Apicomplexa,* which is characterized by the presence of distinct apical organelles consisting of micronemes, dense granules, and rhoptries that are used by the parasite for host invasion and gliding motility ([@bib2]). Of the three invasive stages (sporozoites, merozoites, and ookinetes), the ookinete uniquely lacks rhoptries and dense granules.

In most organisms, processes involved in cell cycle, differentiation, and development are regulated by reversible phosphorylation of proteins. While kinases are well recognized as important drug targets, the study of protein phosphatases (PPs) has only recently begun to identify them as potential therapeutic targets ([@bib15]; [@bib18]).

Bioinformatic analyses have identified ∼80 kinases and∼30 PP catalytic subunits encoded in the *P. falciparum* genome ([@bib28]; [@bib29]), compared to 518 kinases and 147 PP catalytic subunits identified in the human genome ([@bib18]). Recent systematic functional studies have uncovered the important roles of kinases during signal transduction and various developmental processes in *Plasmodium* ([@bib24]; [@bib25]).

Although complementary functional studies of the *Plasmodium* phosphatome are lacking, its bioinformatic analysis has revealed the presence of nonconventional PPs containing kelch-like motifs as found in plant PPs and two bacterial *Shewanella-*like PPs (Shelphs or SHLP), both lacking orthologs in humans ([@bib29]). SHLPs are related to the phosphoprotein phosphatase (PPP) family of serine/threonine PPs (STPs), span the eukaryote-prokaryote boundary, and are also present in plants, heterokonts, fungi, and some *Protozoa* ([@bib1]; [@bib27]).

In *Plasmodium*, the expression of its two SHLP isoforms in late schizont and merozoite stages has been reported ([@bib11]). Although the γ-proteobacterium *Shewanella* spp. SHLP has been utilized to analyze enzymatic catalysis at low temperatures ([@bib26]), no function of any SHLP is known to date ([@bib13]).

In this study, we have used the rodent malaria *P. berghei* to elucidate the function of *Plasmodium* SHLP1 (PBANKA_133240) during the parasite life cycle using reverse genetics, biochemical and cell biological approaches.

Results and Discussion {#sec2}
======================

Bioinformatics of *Shewanella*-like Protein Phosphatases in *Plasmodium* {#sec2.1}
------------------------------------------------------------------------

We confirmed the presence of two genes in the *P. berghei* genome encoding *Shewanella*-like PPs: PBANKA_133240, which has a signal peptide and apicoplast targeting sequence and PBANKA_060470, which were named *Shewanella*-like protein phosphatases SHLP1 and SHLP2, respectively.

In eukaryotes other than in *Apicomplexa*, SHLPs have been found in, *Archaeplastida*, some fungi, and some *Chromalveolates* and are structurally related to a class of bacterial PPPs first identified in the psychrophilic bacteria *Shewanella* and *Colwellia* ([@bib26]). Consequently, a phylogenetic tree was constructed from multiple alignments of 47 SHLP-related amino acid sequences ([Figure 1](#fig1){ref-type="fig"}A; [Table S1](#mmc1){ref-type="supplementary-material"}) that confirmed the presence of SHLPs in the examined species in addition to flowering plants ([@bib13]; [@bib27]). Both PbSHLP1 and PbSHLP2 show higher identity to AtSLP2 than AtSLP1 ([Table S1](#mmc1){ref-type="supplementary-material"}) and form a distinct phylogenetic group in *Chromalveolata*.

*Plasmodium* spp. contained two SHLPs, while *Toxoplasma* and *Cryptosporidium* have only one SHLP mostly resembling SHLP2. Sequence analysis of *Plasmodium* SHLPs revealed that only the highly conserved STP catalytic residues ([GD\[I/V/T/L\]HG]{.ul}, [GD]{.ul}\[[L/Y/F]{.ul}\]V\[D/A\]RG, [GNH]{.ul}E, [HGG]{.ul}) and metal ion binding sites (underlined) are largely conserved. The rest of the conserved STP residues, okadaic acid, and microcystin LR inhibitor binding sites, as well as PP1 regulatory subunit binding sites (K[I]{.ul}F, E[F]{.ul}F) and PP1 substrate binding sites are only partially or not conserved ([Figure S1](#figs1){ref-type="fig"}). Amino acids involved in PP2A trimeric holoenzyme formation were also absent ([Figure S1](#figs1){ref-type="fig"}).

SHLP1-GFP Is Present in All the Parasite Developmental Stages Examined, Is Preferentially Localized to the Endoplasmic Reticulum, and Is Present in Membrane Fractions {#sec2.2}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------

To study its expression during the *P. berghei* life cycle, we generated a C-terminal GFP fusion protein using endogenous *shlp1* (PBANKA_133240) and single crossover recombination ([Figures S2](#figs2){ref-type="fig"}A--S2C). SHLP1-GFP showed diffuse fluorescence staining in all parasite stages examined by microscopy with prominent staining in the asexual stages, the male gamete, and oocyst ([Figure 1](#fig1){ref-type="fig"}B). However, despite the presence of a predicted apicoplast targeting signal, the protein was found distributed nonuniformly throughout the parasite body in all stages analyzed ([Figure 1](#fig1){ref-type="fig"}B) and colocalized with ER tracker Red, suggesting that SHLP1-GFP is located in the endoplasmic reticulum (ER) ([Figure 1](#fig1){ref-type="fig"}C). This was further confirmed by high-resolution imaging ([Figure S1](#figs1){ref-type="fig"}B). Furthermore, subcellular fractionation of asexual blood stages using hypotonic lysis and carbonate solubility recovered most of the SHLP1-GFP protein in the carbonate soluble (peripheral membrane) and carbonate insoluble (integral membrane proteins) fractions, suggesting a membrane localization of the protein in the ER. GFP alone in the control was in the soluble (cytosolic) fraction and GAP45 control was found in the integral membrane fraction ([Figure 1](#fig1){ref-type="fig"}D).

A cytosolic localization has recently been described for AtSLP2 (At1g18480), whereas AtSLP1 was located in the chloroplast ([@bib27]); *P. falciparum* SHLP2 (PF3D7_1206000) was recently identified at the apical end of the merozoite ([@bib11]).

SHLP1 Has Phosphatase Enzyme Activity and Is Not Itself Phosphorylated in Schizonts or Activated Gametocytes {#sec2.3}
------------------------------------------------------------------------------------------------------------

We investigated whether SHLP1 is an active phosphatase in *P. berghei* using the SHLP1-GFP protein expressed in vivo and 3-O-methylfluorescein phosphate (MFP) as a substrate. SHLP1-GFP displayed phosphatase activity proportional to the amount of lysate in the assay; wild-type (WT) parasite extracts not expressing GFP and WT and SHLP1-GFP controls without MFP substrate produced almost no signal. The basal fluorescence level observed in GFP control lysates was likely due to GFP fluorescence, as the signal was still present in the absence of MFP substrate ([Figure 2](#fig2){ref-type="fig"}A, upper panel). Unlike classical eukaryotic PPP, which are specific for Ser and Thr residues, bacterial PPPs may have broader substrate specificity, and the cold-active phosphatase originally described in *Shewanella* is a Tyr PP ([@bib26]). MFP is hydrolyzed by both Ser/Thr- and Tyr-specific PPs, and, since SHLP1 is related to the STP family of PPs, we tested for activity in the presence of the PPP inhibitors okadaic acid and microcystin-LR. SHLP1-GFP phosphatase activity was not affected by either inhibitor ([Figure 2](#fig2){ref-type="fig"}A, lower panel left), consistent with previous studies with AtSLPs ([@bib27]) and predictions from our bioinformatic analysis ([Figure S1](#figs1){ref-type="fig"}) that *Plasmodium* SHLP1 is divergent in the residues involved in inhibitor binding to type 1 PPs. A PP2A enzyme was used as a positive control in the same assay conditions, and its activity was almost abolished by both inhibitors ([Figure 2](#fig2){ref-type="fig"}A, lower panel right).

As a number of PPs are known to be regulated by phosphorylation ([@bib16]), we analyzed SHLP1-GFP phosphorylation in vivo. Although activated gametocytes and schizonts from WT-GFP- and SHLP1-GFP-expressing parasite lines incorporated ^32^P-orthophosphate into the total complement of proteins ([Figure 2](#fig2){ref-type="fig"}B, upper panel), SHLP1-GFP was not phosphorylated at either stage ([Figure 2](#fig2){ref-type="fig"}B, middle panel, arrow), though detectable by western blot ([Figure 2](#fig2){ref-type="fig"}B lower panel), consistent with data from previous global phosphoproteomics studies of *P. falciparum* schizonts ([@bib14]).

SHLP1 Is Critical to Ookinete Formation, Ookinete-to-Oocyst Transition, and Parasite Transmission {#sec2.4}
-------------------------------------------------------------------------------------------------

To elucidate the function of SHLP1 during the *Plasmodium* life cycle, we replaced the endogenous *shlp1* gene with a *T. gondii dhfr/ts* selectable marker using double homologous recombination ([Figures S2](#figs2){ref-type="fig"}D--S2H). Analysis of two deletion mutant clones from two independent transfections identified no phenotypic differences from WT parasites during asexual stages or gametocytogenesis, as assessed on blood smears (data not shown).

Microgametogenesis as assessed by exflagellation was comparable to that of WT parasites ([Figure 3](#fig3){ref-type="fig"}A). Analysis of zygote formation and ookinete development postfertilization in vitro revealed a significant reduction (55%--60%) in ookinete conversion in Δ*shlp1* parasites ([Figure 3](#fig3){ref-type="fig"}B). Time-course analysis revealed that ookinete formation and differentiation was reduced from the onset in Δ*shlp1* mutants (9 hr postfertilization) and thus was not a result of parasite death or dedifferentiation of ookinetes before they reached full maturity at 24 hr ([Figure 3](#fig3){ref-type="fig"}C), in contrast to a previously described phosphodiesterase (*pdeδ*)-deficient parasite ([@bib17]). This suggests that SHLP1 plays an important (though not essential) role at an early stage in ookinete development and differentiation.

For ookinetes that did fully differentiate, we analyzed their motility ([@bib17]) and found that gliding motility in Δ*shlp1* ookinetes was indistinguishable from that of WT parasites ([Figure 3](#fig3){ref-type="fig"}D; [Movies S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}), indicating that their motor function was unimpaired. Parasite motility is governed by an actomyosin motor termed the glideosome, which resides within the pellicle of invasive zoites ([@bib20]). Motility and midgut invasion by the ookinete involves the secretion of a number of membrane proteins, micronemal proteins such as circumsporozoite and TRAP-related protein (CTRP) ([@bib5]; [@bib30]), and secreted ookinete adhesive protein (SOAP) ([@bib6]), as well as the action of the calcium-dependent protein kinases, CDPK3 ([@bib23]) and CDPK1 ([@bib22]).

To extend these findings in vivo, *A. stephensi* mosquitoes were fed on mice infected with either WT or Δ*shlp1* parasites to analyze both oocyst development and sporogony. While the WT developed normally, no Δ*shlp1* oocysts were found on day 14 or 21 postinfection (p.i.) ([Figure 3](#fig3){ref-type="fig"}E). Hence, to determine whether the lack of oocyst formation in Δ*shlp1* mutant parasites was due to a defect in invasion of the midgut epithelium, we bypassed the midgut barrier by injecting ookinetes directly into the hemocoel of *A. stephensi* mosquitoes and analyzed salivary glands for sporozoites 20 days postinjection ([@bib7]). Δ*shlp1* parasites were able to form viable sporozoites, which could migrate to and actively invade the salivary gland ([Figure 3](#fig3){ref-type="fig"}F). Parasite transmission experiments using these mosquitoes resulted in infection of mice with both WT and Δ*shlp1* lines, strongly suggesting that the mutant parasites undergo normal exo- and intraerythrocytic proliferation, but oocyst development in vivo is ablated. Subsequent in vivo invasion assays using *A. gambiae* L3-5 mosquitoes ([@bib4]) with WT and Δ*shlp1* parasites showed a slight but nonsignificant reduction in melanized Δ*shlp1* ookinetes compared to WT ([Figure S3](#figs3){ref-type="fig"}A). These data indicate that Δ*shlp1* ookinetes are able to cross the midgut epithelium but cannot form oocysts.

SHLP1 Function Is Contributed by the Female Gamete {#sec2.5}
--------------------------------------------------

We next examined whether the defect was sex specific by performing genetic crosses between Δ*shlp1* parasites and lines deficient in either male (Δ*map2*) or female (Δ*nek4*) gametes ([@bib25]). We found that only the Δ*map2* mutant was able to rescue the Δ*shlp1* phenotype and form oocysts in the mosquito midgut (p \< 0.001), confirming a strict requirement for a functional female copy of the *shlp1* gene. Ookinetes resulting from female gametocytes with this genotype can be complemented by mutant parasites with viable female forms ([Figure 3](#fig3){ref-type="fig"}G).

SHLP1 Is Important for Microneme Formation in Ookinetes {#sec2.6}
-------------------------------------------------------

To identify whether deletion of *shlp1* results in morphological defects in the viable ookinetes at the ultrastructure level, we analyzed Δ*shlp1* parasites using transmission electron microscopy (TEM). While no defects were found in the apical architecture of Δ*shlp1* ookinetes (i.e., the plasmalemma, inner membrane complex \[IMC\], central aperture, and subpellicular microtubules) ([Figures 4](#fig4){ref-type="fig"}Ai--4Aiii and [S3](#figs3){ref-type="fig"}B), there was a marked reduction in the number of apical micronemes ([Figures 4](#fig4){ref-type="fig"}Aii, 4Aiv, 4Av, and [S3](#figs3){ref-type="fig"}B). Of the various sections examined, 80%--90% of Δ*shlp1* ookinetes had either no apical micronemes ([Figures 4](#fig4){ref-type="fig"}Aiv, 4Av, and [S3](#figs3){ref-type="fig"}B) or had markedly reduced microneme numbers, which were not apically located ([Figures 4](#fig4){ref-type="fig"}Aiv and [S3](#figs3){ref-type="fig"}B).

For confirmation, we performed indirect immunofluorescence and western blotting for proteins associated with either the ookinete motor complex or the micronemes ([Figure 4](#fig4){ref-type="fig"}B). While the glideosome-associated protein 45 (GAP45) and myosin A tail domain-interacting protein (MTIP) displayed no obviously abnormal pattern in the Δ*shlp1* line, micronemal CTRP showed a less distinct apical staining and overall a less intense staining distributed throughout the body of the ookinete relative to that of the WT. Similar differences were observed for microneme-associated SOAP consistent with the marked reduction of micronemes in Δ*shlp1* ookinetes observed by TEM. However, western blot analysis of CTRP and SOAP revealed that overall levels of CTRP were comparable between mutant and WT, whereas SOAP was reduced in the Δ*shlp1* ookinete to 40% of WT levels ([Figure 4](#fig4){ref-type="fig"}C).

The RNA expression profile for female-specific and micronemal genes was comparable for all genes analyzed in WT parasites with the exception of *soap,* which appeared to be upregulated by 2-fold in ookinetes compared to blood and gametocyte stages ([Figure S3](#figs3){ref-type="fig"}C). We used quantitative RT-PCR (qRT-PCR) to investigate whether the defect in microneme formation in the Δ*shlp1* ookinete is accompanied by downregulation of expression of genes encoding ookinete micronemal proteins in activated gametocytes and ookinetes. Of the three genes for micronemal proteins assayed, both *ctrp* and *soap* were significantly downregulated in Δ*shlp1* ookinetes (p \< 0.05 and p \< 0.01, respectively). Expression levels of the invasion-associated chitinase 1 (*cht1*) were completely unaffected in both stages ([Figure 4](#fig4){ref-type="fig"}D). Of the female-specific genes investigated, only *nek4* expression was significantly altered in Δ*shlp1* mutant ookinetes ([Figure S3](#figs3){ref-type="fig"}D).

A variety of micronemal proteins have previously been proposed to have a role in ookinete motility and ookinete to oocyst transition. CTRP deletion mutants are nonmotile and thus do not form oocysts ([@bib5]; [@bib30]), while membrane attack ookinete protein (MAOP) ([@bib12]) and SOAP ([@bib6]) -null mutants are motile but unable or severely impaired in their capability to invade the midgut epithelium, respectively. To date, there is no information on the ultrastructure of these mutant parasites.

It is possible that the absence of micronemes is not due to a lack of cargo but incomplete maturation of the organelles or misdirected trafficking of the proteins as indicated by the diffuse overall staining of CTRP in the Δ*shlp1* cells. De novo biosynthesis of micronemes begins at the Golgi ([@bib21]), which suggests a role for SHLP1 in the regulation of vesicular trafficking and microneme biogenesis. This suggestion is further corroborated by our colocalization and subcellular fractionation data showing SHLP1-GFP in the ER as a peripheral and integral membrane protein. Furthermore, while there is a marked effect on microneme development and ookinete function in the Δ*shlp1* mutant, there is no obvious developmental effect on the other invasive stages (i.e., sporozoites and merozoites) or on asexual development. However, the micronemes of the ookinete are structurally unique with a thin duct connecting the micronemes to the cell apex, a structure that is lacking in other developmental stages. Future studies are needed to understand the function of micronemal proteins and their secretion in the absence of micronemes.

The ability of ookinetes with no micronemes to invade the midgut epithelium has recently been described for a mutant lacking the paternally inherited MISFIT gene, corroborating our finding that mutants with a defect in microneme organelle biogenesis are capable of midgut invasion. However, our genetic complementation result showed that *shlp1* is inherited through the female line, in contrast to MISFIT that showed a paternal effect ([@bib3]).

In summary, our results indicate that SHLP1 in *Plasmodium* is essential for parasite transmission via the mosquito and thus a potential target for the development of transmission-blocking drugs. Ookinete-to-oocyst transition represents one of the biggest bottlenecks in the life cycle of the malarial parasite, and we show here that SHLP1 plays a crucial role in this process.

Experimental Procedures {#sec3}
=======================

See [Extended Experimental Procedures](#dtbox1){ref-type="boxed-text"} for details.

Ethics Statement {#sec3.1}
----------------

All animal work has passed an ethical review process and was approved by the United Kingdom Home Office. Work was carried out in accordance with the United Kingdom "Animals (Scientific Procedures) Act 1986" and in compliance with 'European Directive 86/609/EEC' for the protection of animals used for experimental purposes. The permit number for the project license is 40/3344.

Generation and Genotyping of Transgenic Parasites {#sec3.2}
-------------------------------------------------

To tag the endogenous *shlp1* at the C terminus with GFP, a single homologous recombination technique was used ([@bib8]). To replace *shlp1* by double homologous recombination, a targeting vector was generated using the pBS-DHFR cassette ([@bib25]). See [Extended Experimental Procedures](#dtbox1){ref-type="boxed-text"} for all oligonucleotide sequences and detailed methods.

Bioinformatic Analysis {#sec3.3}
----------------------

Sequence alignments were performed using ClustalW2 and CLC Genomics Workbench (CLC bio, Cambridge, MA). The phylogenetic tree was generated using Fig Tree v1.3.1.

Phenotypic Analysis {#sec3.4}
-------------------

Phenotypic screening was performed as previously described ([@bib8]; [@bib25]). Briefly, asexual proliferation and gametocytogenesis were analyzed using blood smears. Gametocyte activation, zygote formation, and ookinete conversion rates were monitored in in vitro cultures using as a marker the surface antigen P28. For mosquito transmission, triplicate sets of 20--60 *Anopheles stephensi* were used.

Purification of Schizonts, Gametocytes, and Ookinetes {#sec3.5}
-----------------------------------------------------

Schizonts, gametocytes, and ookinetes were purified as described previously ([@bib8]).

Quantitative RT-PCR {#sec3.6}
-------------------

Gene expression was quantified from 250 ng of total RNA as previously described ([@bib8]). *hsp70* and *arginyl-tRNA synthetase* were used as reference genes. Primer sequences and cycling conditions are given in [Extended Experimental Procedures](#dtbox1){ref-type="boxed-text"}.

Isolation of SHLP1-GFP Protein, Phosphatase Assay, and Subcellular Fractionation {#sec3.7}
--------------------------------------------------------------------------------

Blood aliquots from parasite-infected mice were incubated in ookinete medium for 30 min at 20°C and processed for protein purification and phosphatase assay as described previously ([@bib8]). Subcellular fractionation was performed using a carbonate method adapted from [@bib10]. Soluble (hypotonic lysis), peripheral membrane (carbonate soluble), and integral membrane (carbonate insoluble) fractions were analyzed by western blotting.

SHLP1 In Vivo Phosphorylation {#sec3.8}
-----------------------------

Purified activated gametocytes and purified schizonts were metabolically labeled with 3--5 MBq ^32^P-orthophosphate for 30 min at 20°C and processed for phosphorylation assay as described previously ([@bib8]).

Injections of Ookinetes into the Mosquito Hemocoel and Genetic Crosses {#sec3.9}
----------------------------------------------------------------------

Hemocoel injection of ookinetes and genetic complementation crosses were carried out as described previously ([@bib7]). See [Extended Experimental Procedures](#dtbox1){ref-type="boxed-text"} for detailed methods.

Electron Microscopy, IFA, and ER Staining {#sec3.10}
-----------------------------------------

Ookinetes cultured and purified as described above were fixed and processed for routine electron microscopy and IFAs were performed on air-dried ookinete slides from ookinete cultures as described recently ([@bib9]). To stain for the ER, ER-Tracker Red (Invitrogen) was used at 2 μM. Blood stages were stained in schizont medium for 60 min at 37°C. Following complete conversion, ookinetes were stained in ookinete medium for 90 min at 25°C. Cells were washed once with respective medium and resuspended in PBS containing Hoechst 33342 DNA stain before being mounting for fluorescent microscopy.

Statistical Analyses {#sec3.11}
--------------------

All statistical analyses were performed using GraphPad Prism (GraphPad Software). For phenotypic analysis, nonparametric Mann-Whitney U tests were used. For RNA expression levels, an unpaired t test was used. For genetic complementation experiments, Kruskal-Wallis one-way ANOVA with Dunn's multiple comparison post hoc test was used.

Extended Experimental ProceduresEthics StatementAll animal work has passed an ethical review process and was approved by the United Kingdom Home Office. Work was carried out in accordance with the United Kingdom 'Animals (Scientific Procedures) Act 1986' and in compliance with 'European Directive 86/609/EEC' for the protection of animals used for experimental purposes. The permit number for the project license is 40/3344.Bioinformatic AnalysisAtSLP1 and AtSLP2 were used in BLAST searches of diverse prokaryote and eukaryotic proteomes to identify 47 SHLP orthologs and *A. thaliana* PPP-family phosphatases were added as an outgroup. The sequences were aligned using ClustalW2 and optimized using CLC Genomics Workbench (CLC bio, Cambridge, MA). After identifying the PP domains, the sequences were realigned using the same program and a neighbor-joining bootstrap tree was generated. The phylogenetic tree was drawn using Fig Tree v1.3.1. Targeting prediction was performed using the prediction of apicoplast targeting sequences (PATS) server (<http://gecco.org.chemie.uni-frankfurt.de/pats/pats-index.php>).AnimalsTuck-Ordinary (TO) (Harlan) outbred mice were used for all experiments except for mosquito infections where C57/Bl6 mice were used.Generation of Transgenic ParasitesThe targeting vector for *shlp1* was constructed using the pBS-DHFR plasmid, which contains polylinker sites flanking a *Toxoplasma gondii dhfr/ts* expression cassette conveying resistance to pyrimethamine. PCR primers P0171 (5′-CCCC[GGGCCC]{.ul}GTTAATATTGAATAACGTTGTCAAC-3′) and P0172 (5′-GGGG[AAGCTT]{.ul}CTATAGCTATAATTTTGCCATTCC-3′) were used to generate a 466 bp fragment of 5′ upstream sequence of *shlp1* from WT genomic DNA, which was inserted into *Apa*I and *Hind*III restriction sites upstream of the *dhfr/ts* cassette of pBS-DHFR. A 498 bp fragment generated with primers P0173 (5′-CCCC[GAATTC]{.ul}CAGGAAAGTCAAACTAATTTGAACCCAG-3′) and P0174 (5′-GGGG[TCTAGA]{.ul}GAACAGAATTTGTATGTGTGAATGTGATC-3′) from the 3′ flanking region of *shlp1* was then inserted downstream of the *dhfr/ts* cassette using *Eco*RI and *Xba*I restriction sites. For transfection a linear fragment was released using *Apa*I and *Xba*I restriction enzymes. Genotyping of transgenic parasites was performed by integration PCR, Southern blotting and PFGE.For GFP-tagging by single homologous recombination, a 703 bp region of *shlp1* starting 383 bp downstream of the ATG start codon and omitting the stop codon was amplified using primers T0801 (5′-CCCC[GGTACC]{.ul}TAGGGTAATATTAATAATGGGAAACCACG-3′) and T0802 (5′-CCCC[GGGCCC]{.ul}CAAAACTGGGTTCAAATTAGTTTGAC-3′). This was inserted upstream of the *gfp* sequence in the pOB277 vector using KpnI and *Apa*I restriction sites. The pOB277 vector contains the human *dhfr* cassette, also conveying resistance to pyrimethamine. Before transfection, the sequence was linearized using *Eco*RV and *P. berghei* ANKA line 2.34 was then transfected by electroporation ([@bib34]). Briefly, electroporated parasites were mixed immediately with 200 μl of reticulocyte-rich blood from a phenylhydrazine (Sigma) treated, naive mouse, incubated at 37°C for 20 min and then injected intraperitoneally into naive mice. From day 1 post infection pyrimethamine (70 μg/ml) (Sigma) was supplied in the drinking water for four days. Mice were monitored for 15 days and drug selection was repeated after passage to a second mouse. Resistant parasites were then used for cloning by limiting dilution and subsequent genotyping.Genotypic Analysis of MutantsFor the gene knockout parasites, two diagnostic PCR reactions were used as illustrated in [Figure S2](#figs2){ref-type="fig"}. Primer 1 (INT P17, 5′-CTATGTTTTACATCAATAATTGCATGG-3′) and primer 2 (ol248, 5′-GATGTGTTATGTGATTAATTCATACAC-3′) were used to determine successful integration of the selectable marker at the targeted locus. Primers 3 (P17 KO1, 5′-GTAAACCCCTATGGAGAATATCATAAAAG-3′) and 4 (P17 KO2, 5′-GGTGTGATGGTTGTCTAGTATGTCCGAC-3′) were used to verify deletion of the gene. Having confirmed integration, genomic DNA from wild-type (WT) and mutant parasites was digested with *Eco*RV and the fragments were separated on a 0.8% agarose gel, blotted onto a nylon membrane (GE Healthcare), and probed with a PCR fragment homologous to the *P. berghei* genomic DNA just outside of the targeted region.Chromosomes of WT and gene knockout parasites were separated by pulsed field gel electrophoresis (PFGE) on a CHEF DR III (BioRad) using a linear ramp of 60--500 s for 72 hr at 4 V/cm. Gels were blotted and hybridized with a probe recognizing both the resistance cassette in the targeting vector and, more weakly, the 3′UTR of the *P. berghei dhfr/ts* locus on chromosome 7.For the C-terminal GFP-tagged parasites, one diagnostic PCR reaction was used as illustrated in [Figure S2](#figs2){ref-type="fig"}. Primer 1 (INT P17tag, 5′-GCCTAATTAGGTGCAACTTTCGC-3′) and primer 2 (ol492, 5′- ACGCTGAACTTGTGGCCG-3′) were used to determine the correct integration of the *gfp* sequence into the targeted locus. Having confirmed correct integration, parasites were also visualized on a Zeiss AxioImager M2 (Carl Zeiss, Inc) microscope fitted with an AxioCam ICc1 digital camera (Carl Zeiss, Inc) and analyzed by Western blot to confirm GFP expression as described.Phenotypic AnalysisInfections for phenotype screens were initiated by the intraperitoneal injection of infected blood containing 5x10^6^ parasites into mice pretreated with 0.2 ml of 6 mg/ml phenylhydrazine in PBS intraperitoneally to induce reticulocytosis. Asexual stages and gametocyte production were monitored on Giemsa-stained blood films.Exflagellation was examined on days 4-5 post infection. 10 μl of gametocyte-infected blood were obtained from the tail with a heparinized pipette tip and mixed immediately with 40 μl of ookinete culture medium (RPMI1640 containing 25 mM HEPES, 25% fetal bovine serum, 10 mM sodium bicarbonate, 50 μM xanthurenic acid at pH 7.6). The mixture was placed under a Vaseline-coated coverslip and 15 min later exflagellation centers were counted by phase contrast microscopy in 12-15 fields of view using a 63x objective and 10x ocular lens. Ookinete formation was assessed the next day. 10 μl of infected tail blood were obtained as above, mixed immediately with 40 μl ookinete culture medium, and incubated for 2 hr at 20°C to allow completion of gametogenesis and fertilization. Each culture was then diluted with 0.45 ml of ookinete medium and incubated at 20°C for a further 21--24 hr to allow ookinete differentiation. Cultures were pelleted for 2 min at 5000 rpm and then incubating with 50 μl of ookinete medium containing Hoechst 33342 DNA dye to a final concentration of 5 μg/ml and a Cy3-conjugated mouse monoclonal antibody recognizing the P28 protein on the surface of ookinetes (13.1) and any undifferentiated macrogametes or zygotes. P28-positive cells were counted with a Zeiss AxioImager M2 microscope (Carl Zeiss, Inc) fitted with an AxioCam ICc1 digital camera. Ookinete conversion was expressed as the percentage of P28 positive parasites that had differentiated into ookinetes ([@bib35]). Motility assays were performed as previously described ([@bib17]). Briefly, ookinete cultures were mixed with an equal volume of Matrigel on ice, mounted onto a slide, covered and sealed with nail varnish and left to set at room temperature for at least 30 min. Time lapse movies of ookinetes (1 frame every 5 s for 10 min) were taken using a Zeiss AxioImager M2 microscope as described above. Ookinete speed was determined as number of body lengths moved per min.High resolution live cell imaging was performed using an Olympus-based personal Delta Vision work station using a 63x oil immersion objective. Subsequent off line image preparation was carried out using Applied Precision software and images were finalized using Volocity 3D image analysis software (Perkin Elmer). Images presented are 2D projections of 0.1 μM stepped Z-stacks. For mosquito transmission experiments 20-50 *A. stephensi* SD500 or *A. gambiae* L3-5 mosquitoes were allowed to feed for 20 min on anaesthetized infected mice whose asexual parasitaemia had reached ∼7%--23% and were carrying comparable numbers of gametocytes as determined on Giemsa stained blood films. On day 14 post feeding approximately 20 *A. stephensi* mosquitoes were dissected and oocysts on their midguts were counted. Oocyst formation was examined by Hoechst 33342 staining for 10-15 min and guts were washed and mounted under Vaseline-rimmed coverslips. Images were recorded using a 63x oil immersion objective on a Zeiss AxioImager M2 microscope fitted with an AxioCam ICc1 digital camera. Day 21 post feeding another 20 mosquitoes were dissected and their guts and salivary glands crushed separately in a loosely fitting homogenizer to release sporozoites, which were then quantified using a haemocytometer. Due to day-to-day variations in transmission levels, all data were normalized to a matching number of WT controls analyzed on the same day.*A. gambiae* L3-5 guts were analyzed on day 8 p.i. for the presence of melanised ookinetes. Briefly, guts were fixed in 4% formaldehyde/PBS, washed 3 times in PBS and mounted in Vectashield (Vector laboratories).Genetic Crosses and Haemocoel InjectionsGenetic complementation crosses were carried out between different mutant parasite lines as described ([@bib7]). Briefly, Mice were infected with combinations of different strains and 3-6 days old female *A. stephensi* mosquitoes were infected by directly feeding on these mice. Mosquitoes were dissected 12-14 days post infection and the presence of oocysts was determined.For haemocoel injections, *A. stephensi* mosquitoes were anaesthetised with CO~2~ and injected into the thorax with approximately 500 ookinetes harvested from standard cultures in 69 μl of complete ookinete medium using a microinjector (Drummond, Nanoject II). 20 days post-injection bite-back infections of mice and salivary gland dissections for quantification of sporozoites were performed.Purification of Schizonts, Gametocytes, and OokinetesPurification of gametocytes was achieved using a protocol modified from ([@bib31]). Mice were treated by intraperitoneal injection of 0.2 ml of phenylhydrazine (6 mg/ml) (Sigma) in PBS to encourage reticulocyte formation four days prior to infection with parasites. Day four post infection (p.i.) mice were treated with sulfadiazine (Sigma) at 20 mg/l in their drinking water for two days to eliminate asexual blood stage parasites. On day six p.i. mice were bled by cardiac puncture into heparin and gametocytes separated from uninfected erythrocytes on a 48% v/v NycoDenz gradient (Stock: 27.6% w/v NycoDenz in 5 mM Tris-HCl, pH 7.20, 3 mM KCl, 0.3 mM EDTA) in coelenterazine loading buffer (CLB), containing PBS, 20 mM HEPES, 20 mM Glucose, 4 mM sodium bicarbonate, 1 mM EGTA, 0.1% w/v bovine serum albumin, pH 7.25. Gametocytes were harvested from the interface and washed twice in RPMI 1640 ready for activation of gamete formation. Blood cells from day 5 p.i. mice were placed in culture for 24 hr at 37°C for schizont (with rotation at 100 rpm) and 20°C for ookinete production as described above. Schizonts and ookinetes were purified on a 60% v/v and 63% v/v NycoDenz gradient, respectively and harvested from the interface and washed.Quantitative RT-PCRParasites were purified from blood and the RNA was isolated using Trizol (Sigma) according to the manufacturer's instructions. Purified RNA was treated with DNase I (QIAGEN) and cDNA was synthesized using the high capacity RNA-to-cDNA kit (Applied Biosystems). Gene expression was quantified from 250 ng of total RNA. qPCR reactions consisted of 2.5 μl of cDNA, 5 μl SYBR green fast master mix (Applied Biosystems), 0.5 μl (250 nM) each of the forward and reverse primers, and 1.5 μl DEPC-treated water. All of the primers were designed either with PerlPrimer ([@bib36]) or primer3 (Primer-blast, NCBI) design software and were 18-24 bp in length, containing 40%--60% GC content, amplified a region 70-200 bp long and where possible, annealing within 600 bp of the 3′ end of the gene of interest.Analysis was conducted using an Applied Biosystems 7500 fast machine with the following cycling conditions: 95°C for 20 s followed by 40 cycles of 95°C for 3 s; 60°C for 30 s. Three biological replicates, consisting of three technical replicates, were performed for each assayed gene. Wild-type and relative expression were determined using qBasePlus v1.3 (Biogazelle) ([@bib33]; [@bib38]), with relative quantification in mutant lines normalized against wild-type expression. Both methods used *hsp70* (PBANKA_081890) (forward, 5′-GTATTATTAATGAACCCACCGCT-3′; reverse, 5′-GAAACATCAAATGTACCACCTCC-3′) and *arginyl-tRNA synthetase* (PBANKA_143420) (forward, 5′-TTGATTCATGTTGGATTTGGCT-3′; reverse, 5′-ATCCTTCTTTGCCCTTTCAG-3′) as reference genes. *shlp1* primers were: forward, 5′-CATCACACCAAATTGGCTCTT-3′; reverse, 5′-AATTCGGATAAGGCTGACCA-3′. *dozi* (PBANKA_121770) primers were: forward, 5′- GCAAGAATGTCGCAAACAC-3′; reverse, 5′-TCTGAGGAAACTAAACATCGAC-3′. *nek4* (PBANKA_061670) primers were: forward, 5′-CTTCAGATGTATGGGCTATTGG-3′; reverse, 5′- TTCCCTTTGTTGAATGAAATGG-3′. *cht1* (PBANKA_080050) primers were: forward, 5′- ACGTTGACTACCCAACAGGA-3′; reverse, 5′-ATCCTGGGCAGCTGTATTCG-3′. *cith* (PBANKA_130130) primers were: forward, 5′- ATAGTAACATACAGGTAGGAGGA-3′; reverse, 5′-CCGAAAGTATCAACATCTAGCA-3′. *ctrp* (PBANKA_041290) primers were: forward, 5′- ACCTCCCGTTTTAGATGGATCG-3′; reverse, 5′-ATGTGGTGTCTCTCCTCCATT-3′. *soap* (PBANKA_103780) primers were: forward, 5′- AAGGCATCTTCACGATCCGA-3′; reverse, 5′-TTAGTCCCTTTGCATGTGCG-3′.Immunofluorescence AssaysThin blood films were prepared from ookinete cultures and air-dried. For various antibodies different procedures were followed. For anti-GAP45, anti-MTIP and anti-SOAP staining, slides were fixed for 10 min in 4% paraformaldehyde in MTSB buffer and for CTRP slides were fixed for 5 min in 1% formaldehyde. Concentrations of primary antibodies were: 1:250 for both rabbit antibodies against GAP45 and MTIP ([@bib32]), 1:1000 for the mouse monoclonal anti-CTRP antibody ([@bib5]) and 1:100 for mouse anti-SOAP ([@bib6]). Secondary antibodies used were Alexa Fluor 488 goat anti-rabbit, Alexa Fluor 488 goat anti-mouse and Alexa Fluor 568 goat anti-mouse (all 1:1000) from Invitrogen.Subcellular FractionationThe protocol used for subcellular fractionation was adapted from ([@bib10]). Briefly, blood aliquots from infected mice (with WT-GFP and SHLP1-GFP parasites) were prepared as described previously ([@bib8]). The parasite pellets obtained were resuspended in hypotonic lysis buffer (10mM Tris-HCl pH 8.4, 5mM EDTA) containing protease inhibitors (Roche), freeze-thawed twice, incubated for 1 hr at 4°C and centrifuged at 100,000 g for 30 min. The supernatants were collected as the soluble protein fraction (S). The pellets were then washed, resuspended in carbonate solution (0.1M Na~2~CO~3~ pH 11.0) containing protease inhibitors (Roche), incubated for 30 min at 4°C and centrifuged at 100,000 g for 30 min. The supernatants were saved as the peripheral membrane fraction (PM) and the pellets were washed and solubilized in 4% SDS and 0.5% Triton X-100 in PBS, forming the integral membrane fraction (IM). Equal amounts of these three fractions were then analyzed by western blot using anti-GFP antibody. A control using anti-GAP45 antibody was used to confirm the presence of the integral membrane GAP45 in the carbonate insoluble (IM) fraction ([@bib37]).Western BlottingWestern blot analysis was performed on cell lysates prepared by re-suspending parasite pellets in a 1:1 ratio of PBS containing Protease inhibitor (Roche) and either Laemmli sample buffer (anti-SOAP, anti GAP45 and anti-GFP blots) or non-reducing SDS buffer (CTRP), boiling and separating on either 4%--15% gradient or 12% SDS-polyacrylamide gel. Samples were subsequently transferred to nitrocellulose membranes (Amersham Biosciences) and immunoblotting was performed using the Western Breeze Chemiluminescent Anti-Rabbit and Anti-Mouse kit (both Invitrogen) according to the manufacturer's instructions. Primary antibody concentrations were: anti-GFP rabbit polyclonal (Invitrogen) 1:1250, anti-GAP45 rabbit polyclonal ([@bib32]) 1:5000, mouse monoclonal anti-CTRP antibody ([@bib5]) 1:10,000 and mouse anti-SOAP ([@bib6]) 1:2000. Band intensities quantification was done using the ImageJ software (National Institutes of Health).Phosphatase Activity AssayProtein phosphatase activity of the immunoprecipitated SHLP1-GFP was assessed using the SensoLyte MFP Protein Phosphatase Assay Kit (AnaSpec) according to manufacturer's instructions. Briefly, blood aliquots from infected mice (with WT, WT-GFP and SHLP1-GFP parasites) were incubated in ookinete medium for 30 min at 20°C and processed as described previously ([@bib8]). The parasite pellets obtained were lysed for 30 min at 4°C in lysis buffer (ChromoTek) supplemented with protease inhibitors (Roche), the resulting lysates were then immunoprecipitated using GFP-TRAP beads (ChromoTek) according to manufacturer's instructions. The GFP-TRAP beads were resuspended and diluted in phosphatase assay buffer (100 mM Tris-HCl pH 7.5, 4 mM DTT, 0.2 mM EDTA, 0.5 mM MnCl~2~, 0.4 mg/ml BSA), incubated for 30 min at 37°C in the presence or absence of MFP fluorogenic phosphatase substrate, and centrifuged for 2 min at 2700 g. Supernatants were transferred to a 96-well microplate and the fluorescence generated by the dephosphorylation of MFP was measured using a microplate fluorimeter. A recombinant PP2A enzyme (Cayman Chemical) was used as positive control for the assay.SHLP1 In Vivo PhosphorylationAs described previously ([@bib8]), schizonts and activated gametocytes (purified as described above) were washed in phosphate-free Krebs buffer (118 mM NaCl, 4.7 mM KCl, 4.2 mM NaHCO~3~, 1.2 mM MgSO~4~, 11.7 mM glucose, 10 mM HEPES, 1.3 mM CaCl~2~, pH 7.4) and metabolically labeled with 3-5 MBq ^32^P-orthophosphate (Perkin Elmer) in phosphate-free Krebs buffer for 30 min at 20°C or 37°C for activated gametocytes and schizonts, respectively. After two washes in phosphate-free Krebs buffer, the labeled parasites were lysed for 30 min at 4°C in lysis buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP-40) supplemented with protease and phosphatase inhibitors (Roche), the resulting lysate was centrifuged at 20,000 g for 5 min and the supernatant collected. GFP tagged proteins were isolated using GFP-TRAP beads (ChromoTek), the immunoprecipitated proteins were then resuspended in Laemmli sample buffer and separated by SDS-PAGE. ^32^P-labeled proteins were visualized using a phosphorimager (Molecular Dynamics) and GFP-tagged proteins analyzed by western blot as described above.
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![Phylogenetic Analysis and Expression of SHLP1 during Parasite Development\
(A) Multiple alignment of the catalytic domains of SHLP proteins excluding positions with a gap in any sequence was used to construct a phylogenetic tree by the neighbor-joining method and using Kimura's empirical correction for multiple hits with 100 bootstrapped replicates implemented in ClustaW2. The PP catalytic domains were identified by the conserved PPP specific motifs "GD(L/I/V)HG" at the N-terminal and the "(I/L/V)D(S/T/G)" at the C-terminal region. *A. thaliana* PPP family PPs were used as an out group in the analysis. Species and gene abbreviations are outlined in [Table S1](#mmc1){ref-type="supplementary-material"}. Trypanosome *T. brucei* (*Tb*), *T. cruzi* (*Tc*), and *L. major* (*Lm*j) PP domains are indicated by systematic gene IDs. Bootstrap values of 50% and above for the nodes are shown. The scale bar indicates 0.1 substitutions per site.\
(B) SHLP1-GFP expression in transgenic parasites. A Cy3-conjugated antibody recognizing P28 on the surface of activated females, zygotes, and ookinetes was used in the sexual stages. Scale bar, 5 μm.\
(C) Costaining with ER-tracker Red shows association of SHLP1-GFP with the ER. Scale bar, 10 μm.\
(D) WT-GFP and SHLP1-GFP subcellular fractionation. Anti-GFP (left two panels) and anti-GAP45 (right panel) western blot of soluble (S), peripheral membrane (PM), and integral membrane (IM) fractions.\
See also [Figure S1](#figs1){ref-type="fig"}.](gr1){#fig1}

![SHLP1-GFP Phosphatase Activity and In Vivo Phosphorylation Levels\
(A) Upper panel: phosphatase activity in immunoprecipitates from lysates of SHLP1-GFP, WT-GFP, and WT parasite lines with or without MFP substrate and anti-GFP western blot showing amounts of SHLP1-GFP and WT-GFP retained from the corresponding lysates. Lower panel: phosphatase activity of the same immunoprecipitates (left, from 30 μg total protein) and of recombinant PP2A control (right, 0.1 U) in the presence or absence of okadaic acid (OA, 120 nM) and microcystin-LR (MC-LR, 10 nM). Error bar ±SEM, n = 3.\
(B) Upper panel: autoradiograph of ^32^P-labeled total protein lysates before immunoprecipitation in activated gametocytes (AG) and schizonts (Sch) from WT-GFP, SHLP1-GFP, and PPKL-GFP (+C) parasites. Middle panel: autoradiograph showing phosphorylation of GFP-TRAP immunoprecipitated lysates. Lower panel: corresponding western blot using anti-GFP antibody on the immunoprecipitates. Arrow shows the position of SHLP1-GFP on the gels, and the star marks the position of phosphorylated PPKL-GFP ([@bib9]).](gr2){#fig2}

![Phenotypic Analyses of Δ*shlp1* Mutants: Ookinete Formation and Oocyst Development Are Affected\
(A) Microgametogenesis in WT and Δ*shlp1* mutant lines measured as number of exflagellation centers (ns = not significant, Mann-Whitney U test, p \> 0.05).\
(B) Ookinete conversion in Δ*shlp1* mutants compared to WT (Mann-Whitney U test, ^∗∗∗^p \< 0.001). Data shown as mean ±SD.\
(C) Developing ookinete stages shown as the percentage of female-derived cells for WT and Δ*shlp1* with the correct shape at either 9 hr (stages I--III) or 24 hr (fully differentiated ookinete) postfertilization. Data shown as mean ±SD.\
(D) Representative frames from time-lapse movies of WT (upper panels) and Δ*shlp1* (lower panels) ookinetes in Matrigel. Arrow indicates the apical end of the ookinete. Bar = 10 μm. Velocity of individual WT or Δ*shlp1* ookinetes from 24 hr cultures was measured over 10 min, as shown in the dot plot. Bar = arithmetic mean; n = 18 for WT and 22 for Δ*shlp1* lines.\
(E) Numbers of oocysts in *A. stephensi* midguts on day 14 postblood feeding show complete ablation of oocyst development in Δ*shlp1* parasites compared to WT (Mann-Whitney U test, ^∗∗∗^p \< 0.001).\
(F) Hemocoel injection of Δ*shlp1* ookinetes shows that mutant sporozoites invade the salivary glands, can be successfully transmitted to mice, and are able to establish new infections.\
(G) Genetic complementation of Δ*shlp1* parasites. Mosquitoes were fed on mice infected with WT or Δ*shlp1* mutant alone or coinfected with Δ*shlp1* and either a Δ*map2* mutant or a Δ*nek4* mutant. Scale bar, 100 μm (Kruskal-Wallis test, ^∗∗∗^p \< 0.001).\
See also [Figure S2](#figs2){ref-type="fig"}.](gr3){#fig3}

![Microneme Reduction and Mislocalization in *Δshlp1* Ookinetes\
(A) (i) Transmission electron micrograph (TEM) of a longitudinal section through a WT ookinete showing the conical apical end. The cytoplasm contains a number of apically located micronemes (M) and a more posteriorly located nucleus (N). Scale bar, 1 μm. (ii) Longitudinal TEM section through a Δ*shlp1* ookinete showing substantial reduction of micronemes and mislocalization of remaining micronemes at the posterior end. Bar = 1 μm. (iii) Enlargement of the anterior of a WT ookinete showing the complex nature of the apical end consisting of a conical shaped electron dense collar (C) with a central aperture and an underlying less electron dense ring (R). Micronemes (M) are located within the cytoplasm. Scale bar, 100 nm. (iv and v). Detail of the anterior of *Δshlp1* ookinetes showing reduction in micronemes (M). Scale bar, 100 nm.\
(B) Indirect immunofluorescence of a number of motor complex and micronemal proteins in WT and *Δshlp1* ookinetes. Compared to WT, staining for micronemal proteins SOAP and CTRP was reduced in the Δ*shlp1* mutant and spread throughout the cell body as opposed to the normal concentration at the apical end (arrow). No difference was observed between WT and mutant ookinetes for glideosomal GAP45 and MTIP.\
(C) Western blot analyses of ookinete micronemal proteins CTRP and SOAP. Expression levels were compared between WT and Δ*shlp1* ookinetes and normalized to the GFP control using ImageJ software. CTRP expression was unaltered in the mutant whereas SOAP expression was reduced to 40%.\
(D) Relative RNA expression of microneme specific genes *cht1*, *ctrp*, *and soap* in Δ*shlp1* mutant parasites compared to WT controls. Each point is the mean of three biological replicates ±SD (normalized using qBasePlus). AG, activated gametocytes; OO, ookinete. ^∗^p \< 0.05; ^∗∗^p \< 0.01.\
See also [Figure S3](#figs3){ref-type="fig"}.](gr4){#fig4}

![Sequence Alignment of the *Plasmodium* spp SHLPs, Related to [Figure 1](#fig1){ref-type="fig"}\
(A) The invariant residues conserved in protein phosphatases are highlighted in gray and metal ion binding sites are marked with solid circles. The amino acids with role in inhibitor binding are highlighted: Inhibitor-2 binding amino acids (1.-7. blue squares); microcystin binding amino acids (1.-4. orange squares); okadaic acid and microcystin binding amino acids (1.-5. green squares); inhibitor-2, microcystin and okadaic acid binding amino acid (1.-2. blue boxes). *A. thaliana* type 1 protein phosphatase (TOPP1) was included in the alignment as marker for the conserved STP residues. The NCBI/GenBank identifiers of the sequences used to construct the alignment can be found in [Table S1](#mmc1){ref-type="supplementary-material"}.\
(B) High resolution 2D projection of SHLP1-GFP asexual blood stage and gametocyte co-stained with ER tracker. Bar = 10 μM.](figs1){#figs1}

![*gfp* Tagging of the Endogenous *shlp1* Locus and Knockout of *shlp1*, Related to [Figure 3](#fig3){ref-type="fig"}\
(A) Schematic representation of the gene targeting strategy used for gene tagging the endogenous locus with *gfp* via single homologous recombination. The C-fusion tag construct contains an insert (white box) homologous to the 3′ end of the *shlp1* ORF fused to *gfp*. A human dehydrofolate reductase selectable marker (*hdhfr*) allows for selection of transgenic parasites. Arrows 1 and 2 indicate primers used for diagnostic PCR.\
(B) Diagnostic integration PCR showing the expected 1.4 kb band and confirming successful integration of the tagging construct.\
(C) Western blot analysis using an anti-GFP (Invitrogen) antibody against protein extracted from gametocytes of WT *P. berghei* ANKA 507 clone 1 constitutively expressing GFP (wt) and transgenic (tag) parasites showing bands of expected sizes of 29 kDa for wild-type-GFP and 71 kDa for SHLP1-GFP.\
(D) Schematic representation of the endogenous *shlp1* locus, the knockout construct and the recombined *shlp1* locus following double cross-over recombination. The knockout construct contains a *Toxoplasma gondii* dehydrofolate reductase/thymidylate synthase (tg dhfr/ts) cassette with a *Pbdhfr* 3′ UTR for selection of transgenic parasites with pyrimethamine. Arrows 1, 2, 3 and 4 indicate binding sites for primers used in integration PCR and knockout PCR. *Eco*RV restriction sites and probe binding sites used for Southern blot analysis are shown.\
(E) Genotypic analysis by integration PCR and knockout PCR. Presence of a 735 bp band using integration specific primers 1 and 2 on gDNA of Δ*shlp1* mutants *cl3* and *cl7 GFP* generated in 507 clone 1 indicates correct integration of the knockout construct. Absence of the 343 bp WT specific band amplified by primers 3 and 4 in both mutants shows loss of the wild-type *shlp1* locus. WT gDNA was used as control.\
(F) Genotypic analysis by Southern blot. gDNA of WT parasites, wild-type 507 clone 1 (*GFPcon*) and Δ*shlp1* mutants *cl3* and *cl7 GFP* was analyzed by Southern blot following *Eco*RV digestion. A probe homologous to the *shlp1* 3′UTR recognizes a 7.8 kb fragment for the endogenous locus and a \> 10 kb fragment for the recombined locus.\
(G) Pulse-field gel electrophoresis blot (PFGE) hybridized with a *Pbdhfr* 3′UTR probe. The probe hybridizes to the endogenous *dhfr* locus on chromosome 7 and the disrupted locus on chromosome 14. (H) Bar graph showing relative expression of endogenous *shlp1* in Δ*shlp1* mutants using qRT-PCR compared to wild-type. Error bars represent ±SEM, n = 3 from three separate experiments in both clone 3 and clone 7 GFP.](figs2){#figs2}

![Phenotypic Analyses of WT and Δ*shlp1* Ookinetes, Related to [Figure 4](#fig4){ref-type="fig"}\
(A) Ookinete invasion assay in *A. gambiae* L3-5 mosquitoes. Microscopy images show melanized ookinetes (arrows) present in mid-guts of mosquitoes infected with either WT control and Δ*shlp1* parasites but not with Δ*ctrp* parasites. Scale bar = 50 μm. The number of melanized Δ*shlp1* ookinetes was not significantly reduced compared to the wild-type, but significantly higher compared to the Δ*ctrp* mutant (Mann-Whitney U-test, ^∗∗∗^ = p \< 0.001).\
(B) Montage of longitudinal sections of the anterior apical end of WT (three left panels) and Δ*shlp1* ookinetes (seven right panels) emphasizing the marked reduction or absence in apical micronemes, whereas all other structures at the apical end appear normal. Bar = 100 nm.\
(C) Normalized wild-type RNA expression of female-specific genes (*cith, dozi* and *nek4), shlp1* and microneme specific genes (*cht1, ctrp* and *soap*), relative to *arginyl-tRNA synthetase* and *hsp70* used as endogenous controls. Each point is the mean of three biological replicates consisting of three technical replicates ±SD (normalized using qBasePlus).\
(D) Relative RNA expression of female-specific genes (*cith, dozi, nek4*) and *shlp1* (relative to *arginyl-tRNA synthetase* and *hsp70)* in Δ*shlp1* mutant parasites compared to wild-type controls. Each point is the mean of three biological replicates consisting of three technical replicates ±SD (normalized using qBasePlus).\
Asexual blood = ASB; Activated gametocytes = AG; Ookinete = OO. ^∗^ = p \< 0.05; ^∗∗^ = p \< 0.01.](figs3){#figs3}
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